These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29707994)

  • 1. High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancer.
    Yu J; Zhou J; Xu F; Bai W; Zhang W
    Int J Biol Markers; 2018 May; 33(2):215-221. PubMed ID: 29707994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
    Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
    J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aurora B expression modulates paclitaxel response in non-small cell lung cancer.
    Al-Khafaji AS; Davies MP; Risk JM; Marcus MW; Koffa M; Gosney JR; Shaw RJ; Field JK; Liloglou T
    Br J Cancer; 2017 Feb; 116(5):592-599. PubMed ID: 28095398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer.
    Duan FG; Wang MF; Cao YB; Dan Li ; Li RZ; Fan XX; Khan I; Lai HL; Zhang YZ; Hsiao WW; Yao XJ; Wu QB; Liu L; Tang YJ; Leung EL
    Cell Death Dis; 2019 Oct; 10(11):821. PubMed ID: 31659154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.
    Tang F; Hu P; Yang Z; Xue C; Gong J; Sun S; Shi L; Zhang S; Li Z; Yang C; Zhang J; Xie C
    Oncol Rep; 2017 Jun; 37(6):3449-3458. PubMed ID: 28498429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer.
    Takeshita M; Koga T; Takayama K; Ijichi K; Yano T; Maehara Y; Nakanishi Y; Sueishi K
    Lung Cancer; 2013 Apr; 80(1):85-90. PubMed ID: 23313006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA‑328 overexpression confers cisplatin resistance in non‑small cell lung cancer via targeting of PTEN.
    Wang C; Wang S; Ma F; Zhang W
    Mol Med Rep; 2018 Nov; 18(5):4563-4570. PubMed ID: 30221716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
    Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G
    Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression.
    Li GJ; Zhao GQ; Yang JP; Zhou YC; Yang KY; Lei YJ; Huang YC
    Oncol Rep; 2017 Jun; 37(6):3475-3483. PubMed ID: 28498474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis.
    Xu J; Yue CF; Zhou WH; Qian YM; Zhang Y; Wang SW; Liu AW; Liu Q
    J Transl Med; 2014 Jul; 12():200. PubMed ID: 25082261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
    Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
    Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Leung AWY; Veinotte CJ; Melong N; Oh MH; Chen K; Enfield KSS; Backstrom I; Warburton C; Yapp D; Berman JN; Bally MB; Lockwood WW
    Clin Cancer Res; 2017 Nov; 23(21):6555-6566. PubMed ID: 28790117
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor suppressor miR‑613 induces cisplatin sensitivity in non‑small cell lung cancer cells by targeting GJA1.
    Luo J; Jin Y; Li M; Dong L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis.
    Cao L; Chen J; Ou B; Liu C; Zou Y; Chen Q
    Biomed Pharmacother; 2017 Sep; 93():570-579. PubMed ID: 28686971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PINK1 promotes proliferation and chemoresistance of NSCLC.
    Zhang R; Gu J; Chen J; Ni J; Hung J; Wang Z; Zhang X; Feng J; Ji L
    Oncol Rep; 2017 Apr; 37(4):2137-2146. PubMed ID: 28259921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.